News and Announcements
MatLogica is selected into Accenture’s FinTech Innovation Lab London
- Published February 09, 2023 11:45PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
In late 2022, MatLogica was invited to pitch to Accenture’s FinTech Innovation lab (FIL). We are delighted to announce that we are one of 15 start-ups accepted into this prestigious programme!
FinTech Innovation Lab London is a highly competitive, 12-week program that helps innovative startup fintech companies at various stages refine and test their value proposition with the support of the world’s leading financial service firms.
We have now started the 3-month programme filled with masterclasses, mentorship, and access to 35+ world-leading Partner Institutions. Both the mentors and the partners on this programme are a perfect match for us, bringing not only a wealth of experience but also connections to our target customers and potential investors!
Connect with the company and learn more about MatLogica by accessing their deal room here.
Company Updates
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Dying for a Cure: Why Astraea is Stress-Testing the Future of Space Medicine
Astraea Technologies is solving a critical “blind spot” in the $1.5T space economy. Co-founders Brooke Mills and Gordon Carroll discuss their $5M seed raise, the HIRO-LAB platform, and their upcoming 2028 mission to the Moon to validate life-saving medicine in extreme environments.
Beyond the Drip: Elemental IV’s Infrastructure Play for a Fragile Supply Chain
In the high-stakes world of life sciences, we often hunt for the next “miracle molecule” or gene-editing breakthrough. But Storme Paes, Founder and Commercial Director of Elemental IV, found her mission in something far more fundamental, yet dangerously overlooked: a simple bag of saltwater. The “Meeting Room” Revelation The genesis of Elemental IV didn’t occur […]
Backed By Leading Investment Groups and Family Offices
